158 related articles for article (PubMed ID: 24666822)
1. Predictive models for hepatocellular carcinoma.
Naveed M; Waljee AK; Singal AG
Gastroenterology; 2014 May; 146(5):1420-1. PubMed ID: 24666822
[No Abstract] [Full Text] [Related]
2. Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C.
Gavilán JC; Ojeda G; Arnedo R; Puerta S
Eur J Intern Med; 2013 Dec; 24(8):846-51. PubMed ID: 23849588
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous regression of hepatocellular carcinoma.
Kondo S; Okusaka T; Ueno H; Ikeda M; Morizane C
Int J Clin Oncol; 2006 Oct; 11(5):407-11. PubMed ID: 17058140
[TBL] [Abstract][Full Text] [Related]
4. Education and Imaging. Hepatobiliary and Pancreatic: Complete remission after hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with decompensated cirrhosis.
Seo JH; Song MJ
J Gastroenterol Hepatol; 2016 Jan; 31(1):10. PubMed ID: 26177574
[No Abstract] [Full Text] [Related]
5. [Development of hepatocellular carcinoma from chronic hepatitis C].
Yoshida H
Nihon Rinsho; 2011 May; 69 Suppl 4():309-13. PubMed ID: 22096936
[No Abstract] [Full Text] [Related]
6. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
Llovet JM
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):29-35. PubMed ID: 16431301
[No Abstract] [Full Text] [Related]
8. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma complicating biliary cirrhosis caused by biliary atresia: report of a case.
Kohno M; Kitatani H; Wada H; Kajimoto T; Matuno H; Tanino M; Nakagawa T; Takarada A
J Pediatr Surg; 1995 Dec; 30(12):1713-6. PubMed ID: 8749933
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of factors related to prognosis in patients with chronic hepatitis type C--clinical laboratory data].
Matsumoto A; Tanaka E; Kiyosawa K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):430-3. PubMed ID: 15359837
[No Abstract] [Full Text] [Related]
11. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
Iwamura K
Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
[TBL] [Abstract][Full Text] [Related]
12. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
Mehta A; Singal AG
Gastroenterology; 2015 Sep; 149(3):816-7. PubMed ID: 26231605
[No Abstract] [Full Text] [Related]
14. Prevention of mortality from hepatitis B and hepatitis C.
Schiff ER
Lancet; 2006 Sep; 368(9539):896-7. PubMed ID: 16962862
[No Abstract] [Full Text] [Related]
15. Efforts to define the natural history of chronic hepatitis C continue.
Ghany MG; Seeff LB
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1190-2. PubMed ID: 17045209
[No Abstract] [Full Text] [Related]
16. Selenium levels in patients with hepatitis C virus-related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: a pilot study.
Bettinger D; Schultheiss M; Hennecke N; Panther E; Knüppel E; Blum HE; Thimme R; Spangenberg HC
Hepatology; 2013 Jun; 57(6):2543-4. PubMed ID: 23172787
[No Abstract] [Full Text] [Related]
17. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma Surveillance: Moving Forward or Looking in the Rear-View Mirror?
Braillon A
Am J Gastroenterol; 2015 Nov; 110(11):1625. PubMed ID: 26618426
[No Abstract] [Full Text] [Related]
19. Response to Braillon.
Chang TS; Wu YC; Tsai YH; Huang YH
Am J Gastroenterol; 2015 Nov; 110(11):1625-7. PubMed ID: 26618427
[No Abstract] [Full Text] [Related]
20. Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
Zhong YD; Yang YF
Hepatology; 2008 Oct; 48(4):1348; author reply 1348. PubMed ID: 18792394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
